Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sherman

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
BMC Medicine|July 4, 2015
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosisMarcelo Sobral-Leite, Jelle Wesseling, Vincent T H B M Smit, et al.
Ebiomedicine|August 20, 2015
Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in CancerFrancisco J Candido Dos Reis, Stuart Lynn, H Raza Ali, et al.
Cancer Research|March 12, 2009
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancerJoellen M Schildkraut, Ellen L Goode, Merlise A Clyde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancerMaren Weischer, Børge G Nordestgaard, Paul Pharoah, et al.
British Journal of Cancer|January 20, 2017
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility lociSiddhartha P Kar, Emily Adler, Jonathan Tyrer, et al.
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Breast Cancer Research : BCR|November 8, 2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, et al.
The New England Journal of Medicine|November 5, 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, W Marston Linehan, Paul T Spellman, et al.
The New England Journal of Medicine|June 11, 2015
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, Daniel J Brat, Roel G W Verhaak, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
BMC Medicine|July 4, 2015
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosisMarcelo Sobral-Leite, Jelle Wesseling, Vincent T H B M Smit, et al.
Ebiomedicine|August 20, 2015
Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in CancerFrancisco J Candido Dos Reis, Stuart Lynn, H Raza Ali, et al.
Cancer Research|March 12, 2009
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancerJoellen M Schildkraut, Ellen L Goode, Merlise A Clyde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancerMaren Weischer, Børge G Nordestgaard, Paul Pharoah, et al.
British Journal of Cancer|January 20, 2017
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility lociSiddhartha P Kar, Emily Adler, Jonathan Tyrer, et al.
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Breast Cancer Research : BCR|November 8, 2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, et al.
The New England Journal of Medicine|November 5, 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, W Marston Linehan, Paul T Spellman, et al.
The New England Journal of Medicine|June 11, 2015
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, Daniel J Brat, Roel G W Verhaak, et al.
Pageof 6